• Result Found In

Flu Diagnosis

Flu Diagnosis

Flu Diagnose

Accurately Diagnose Flu with Point-of-Care Testing (POCT) Solutions

According to the Center for Disease Control and Prevention (CDC), surveillance systems are detecting a slow but steady increase in influenza (flu). Without the right diagnostic tools, it is very hard to distinguish flu from other viral or bacterial illnesses. As the presence of other respiratory infections rapidly increase due to COVID-19 and other variants, flu screening is more important than ever before.

Ensuring your practice is properly prepared with testing and treatment options is the safest way to provide quality care and a reliable action plan for your patients. Henry Schein Medical offers a robust portfolio of flu testing options that can be administered and read at the point-of-care. With rapid results in minutes, rather than hours and days, it may be possible for you to:

  • Chart the right course of treatment
  • Reduce the severity and durations of symptoms and conditions
  • Improve the patient experience
  • Increase your caseload due to the reduction in time spent with tested patients

The CDC states "Influenza virus testing can inform clinical management when the results may influence clinical decisions such as whether to initiate antiviral treatment, perform other diagnostic testing, or to implement infection prevention and control measures for influenza." Whether it's the flu, COVID-19, or another respiratory illness, accurately diagnosing your patients is at the heart of your treatment plan.

Our flu test portfolio includes molecular, reader and lateral flow options:


ID NOW™ Molecular Instrument - Henry Schein Medical
ID NOW™ Molecular Instrument

ID NOW is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases. The unique ID NOW isothermal nucleic acid amplification technology provides molecular results in just minutes, allowing you to make effective clinical decisions sooner.

  • Small footprint enables ease of use at point of care
  • Simple operation via visual touchscreen
  • Requires minimal training
  • Connectivity can be provided to your network
GeneXpert® Xpress - Henry Schein Medical
GeneXpert® Xpress

Unlock the Power of PCR at Point of Care

The Cepheid GeneXpert Xpress brings the power of CLIA-waived PCR testing to the physician office lab and beyond.

  • CLIA-waived PCR testing: Flu, FLU/RSV, and Strep A
  • Scalable design: 2-module and 4-module options available for customized throughput needs
  • Random access: True on-demand, walkaway testing system that runs up to 4 tests at one time
  • Operator and QC lockout: Customizable features to meet the needs of every practice
  • Built-in redundancy: Each module operates as its own independent analyzer
  • No specialized training or daily maintenance—simple to operate with minimal setup needs
  • Bidirectional interface: Interface to LIS(HL7, ASTM) available

Flu Test Readers

BD Veritor™ Plus System - Henry Schein Medical
BD Veritor™ Plus System

This fast and accurate solution streamlines the point-of-care (POC) diagnostic workflow and allows providers to quickly review patient results and determine the appropriate treatment in a single consultation. The system can help detect infectious diseases such as influenza A and B, respiratory syncytial virus (RSV), and group A strep while the patient is still on site, which can enable faster decision-making for an earlier intervention opportunity.

  • Faster access to test results
  • Improved workflow
  • Improved traceability
  • Modularity
  • Connectivity
Sofia® Influenza A+B FIA Test - Henry Schein Medical
Sofia® Influenza A+B FIA Test

This CLIA-waived test uses advanced immunofluorescence-based lateral-flow technology to detect influenza A and B viral nucleoprotein antigens in nasal and nasopharyngeal swab and nasopharyngeal aspirate/wash specimens taken directly from symptomatic patients.

  • Enhanced assay sensitivity
  • Results in 15 minutes
  • Accurate detection with nasal swab, NP swab and NPA/wash samples
  • Nasal swab sensitivity (A/B): 90%/89%;specificity (A/B): 95%/96%
  • NP swab sensitivity (A/B): 97%/90%;specificity (A/B): 95%/97%
  • NPA/wash sensitivity (A/B): 99%/88%;specificity (A/B): 96%/96%
  • Room temperature storage
  • 21-month shelf life from date of manufacture
  • For use with Sofia Analyzer (sold separately)
  • CLIA-waived for nasal and nasopharyngeal swabs
Abbott DIGIVAL™ - Henry Schein Medical

Accurately reads and interprets lateral flow tests in just seconds, delivering automated, objective results in any health-care setting. It is a camerabased instrument that will detect the presence of, and identify a completed lateral flow assay, analyze the intensity of the test and control line, and display the results (positive, negative, or invalid) on the color touch screen.

  • Small footprint
  • 4.3" color touch screen
  • Barcode scanner and optional printer
  • QC lockout features
  • Workflow flexibility
  • ReadNOW or Walkaway capabilities
  • Data storage: 1000 patient test results
  • 100 QC test results
  • 50 calibration check test results
  • Accurate, objective, rapid results
  • Bidirectional connectivity
Sekisui Acucy™ - Henry Schein Medical
Sekisui Acucy™

The Acucy™ Influenza A&B Test on the Acucy™ System provides clinicians flexibility in workflow and accurate, standardized results for improved patient care.

  • CLIA waived
  • "Read Now" or "Walk Away" modes
  • Results within 15 minutes
  • Nasal and nasopharyngeal swab types
  • Includes 2 additional tests for quality-control testing

Lateral Flow Flu Tests

Henry Schein OneStep™ + Ultra Flu Test - Henry Schein Medical
Henry Schein OneStep™ + Ultra Flu Test

Intended for the qualitative detection of influenza type A and type B nucleoprotein antigens directly from nasal and nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection.

  • CLIA waived
  • Results in 10 minutes
  • Sensitivity (A/B): 90.3%/88%
  • Specificity (A/B): 96.7%/99.2%
  • For use with nasal and nasopharyngeal swab specimens
QuickVue® Influenza Test - Henry Schein Medical
QuickVue® Influenza Test

An immunoassay for detecting influenza types A and B. Three simple steps with results in 10 minutes or less. Color-coded procedure card helps demonstrate each step of test. Kit contains positive and negative controls, and stores at room temperature.

  • Detects both A and B types of influenza
  • CLIA waived
  • Sensitivity (A/B): 94%/70%
  • Specificity (A/B): 90%/97%
  • Color-coded procedure card helps demonstrate each step of the test
  • No instrumentation needed
  • Results in 10 minutes or less
  • Room-temperature storage